NCT01897766

Brief Summary

The objective of this surveillance is to collect Safety and Effectiveness information for Long term Use of Somatropin for Patients with a Small for Gestational Age (SGA).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
482

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2013

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 12, 2013

Completed
2 months until next milestone

Study Start

First participant enrolled

September 5, 2013

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 7, 2017

Completed
2.7 years until next milestone

Results Posted

Study results publicly available

February 11, 2020

Completed
Last Updated

September 25, 2023

Status Verified

August 1, 2023

Enrollment Period

3.5 years

First QC Date

July 9, 2013

Results QC Date

February 26, 2018

Last Update Submit

August 31, 2023

Conditions

Keywords

GenotropinSomatropinLong Term Follow-UpSpecial InvestigationSmall for Gestational AgeSGA

Outcome Measures

Primary Outcomes (18)

  • Number of Participants With Adverse Drug Reaction (ADR)

    An adverse drug reaction (ADR) was any untoward medical occurrence attributed to Genotropin in a participant who received Genotropin. A serious ADR (SADR) was an ADR resulting in any of the following out comes or deemed significant for any other reason: death; life-threatening experience (immediate risk of dying); initial or prolonged inpatient hospitalization; persistent or significant disability/incapacity; congenital anomaly. Relatedness to Genotropin was assessed by the physician.

    Approximately 11.58 years

  • Change in Height Velocity Standard Deviation (SD) Score for Chronological Age From Baseline At Year 1

    Change in height Velocity SD score from baseline was calculated. Height Velocity SD score = (Height - Standard height for chronological age of gender) / SD. An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score. SD score indicates how similar participant was to reference population.

    Baseline, Year 1

  • Change in Height Velocity Standard Deviation (SD) Score for Chronological Age From Baseline at Year 2

    Change in height Velocity SD score from baseline was calculated. Height Velocity SD score = (Height - Standard height for chronological age of gender) / SD. An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score. SD score indicates how similar participant was to reference population.

    Baseline, Year 2

  • Change in Height Velocity Standard Deviation (SD) Score for Chronological Age From Baseline at Year 3

    Change in height Velocity SD score from baseline was calculated. Height Velocity SD score = (Height - Standard height for chronological age of gender) / SD. An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score. SD score indicates how similar participant was to reference population.

    Baseline, Year 3

  • Change in Height Velocity Standard Deviation (SD) Score for Chronological Age From Baseline at Year 4

    Change in height Velocity SD score from baseline was calculated. Height Velocity SD score = (Height - Standard height for chronological age of gender) / SD. An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score. SD score indicates how similar participant was to reference population.

    Baseline, Year 4

  • Change in Height Velocity Standard Deviation (SD) Score for Chronological Age From Baseline at Year 5

    Change in height Velocity SD score from baseline was calculated. Height Velocity SD score = (Height - Standard height for chronological age of gender) / SD. An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score. SD score indicates how similar participant was to reference population.

    Baseline, Year 5

  • Change in Height Velocity Standard Deviation (SD) Score for Chronological Age From Baseline at Year 6

    Change in height Velocity SD score from baseline was calculated. Height Velocity SD score = (Height - Standard height for chronological age of gender) / SD. An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score. SD score indicates how similar participant was to reference population.

    Baseline, Year 6

  • Change in Height Velocity Standard Deviation (SD) Score for Chronological Age From Baseline at Year 7

    Change in height Velocity SD score from baseline was calculated. Height Velocity SD score = (Height - Standard height for chronological age of gender) / SD. An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score. SD score indicates how similar participant was to reference population.

    Baseline, Year 7

  • Change in Height Velocity Standard Deviation (SD) Score for Chronological Age From Baseline at Year 10

    Change in height Velocity SD score from baseline was calculated. Height Velocity SD score = (Height - Standard height for chronological age of gender) / SD. An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score. SD score indicates how similar participant was to reference population.

    Baseline, Year 10

  • Change in Height Standard Deviation (SD) Score for Chronological Age From Baseline at Year 1

    Change in height SD score from baseline was calculated. Height SD score = (Height - Standard height for chronological age of gender) / SD. An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score. SD score indicates how similar participant was to reference population.

    Baseline, Year 1

  • Change in Height Standard Deviation (SD) Score for Chronological Age From Baseline at Year 2

    Change in height SD score from baseline was calculated. Height SD score = (Height - Standard height for chronological age of gender) / SD. An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score. SD score indicates how similar participant was to reference population.

    Baseline, Year 2

  • Change in Height Standard Deviation (SD) Score for Chronological Age From Baseline at Year 3

    Change in height SD score from baseline was calculated. Height SD score = (Height - Standard height for chronological age of gender) / SD. An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score. SD score indicates how similar participant was to reference population.

    Baseline, Year 3

  • Change in Height Standard Deviation (SD) Score for Chronological Age From Baseline at Year 4

    Change in height SD score from baseline was calculated. Height SD score = (Height - Standard height for chronological age of gender) / SD. An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score. SD score indicates how similar participant was to reference population.

    Baseline, Year 4

  • Change in Height Standard Deviation (SD) Score for Chronological Age From Baseline at Year 5

    Change in height SD score from baseline was calculated. Height SD score = (Height - Standard height for chronological age of gender) / SD. An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score. SD score indicates how similar participant was to reference population.

    Baseline, Year 5

  • Change in Height Standard Deviation (SD) Score for Chronological Age From Baseline at Year 6

    Change in height SD score from baseline was calculated. Height SD score = (Height - Standard height for chronological age of gender) / SD. An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score. SD score indicates how similar participant was to reference population.

    Baseline, Year 6

  • Change in Height Standard Deviation (SD) Score for Chronological Age From Baseline at Year 7

    Change in height SD score from baseline was calculated. Height SD score = (Height - Standard height for chronological age of gender) / SD. An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score. SD score indicates how similar participant was to reference population.

    Baseline, Year 7

  • Change in Height Standard Deviation (SD) Score for Chronological Age From Baseline at Year 9

    Change in height SD score from baseline was calculated. Height SD score = (Height - Standard height for chronological age of gender) / SD. An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score. SD score indicates how similar participant was to reference population.

    Baseline, Year 9

  • Change in Height Standard Deviation (SD) Score for Chronological Age From Baseline at Year 10

    Change in height SD score from baseline was calculated. Height SD score = (Height - Standard height for chronological age of gender) / SD. An SD score indicates how far a participant's score deviates from the mean of the reference population; an SD score higher than the mean gives a positive SD score whereas an SD score lower than the mean gives a negative SD score. SD score indicates how similar participant was to reference population.

    Baseline, Year 10

Secondary Outcomes (2)

  • Height Standard Deviation (SD) Score at Puberty and at Near Final Height in Participants Who Reached Near Final Height

    Baseline, At Puberty, At Near Final Height within the span of approximately maximum of 11.58 years

  • Change in Height Standard Deviation (SD) Score at Puberty and at Near Final Height in Participants Who Reached Near Final Height From Baseline

    Baseline, At Puberty, At Near Final Height within the span of approximately maximum of 11.58 years

Study Arms (1)

Somatropin

Patients administered Somatropin.

Drug: Somatropin

Interventions

0.23 mg to 0.48 mg/kg/week

Also known as: Genotropin
Somatropin

Eligibility Criteria

Age2 Years - 20 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

* A patients who is diagnosed for SGA. (SGA is defined as birth weight and/or length at least 2 standard deviations (SDs) below the mean for gestational age (\<or=-2 SD)). * A patient who is SGA and older than 3 years. * A patient who has persistent short stature (i.e., remaining at least 2.5 SD below the mean for chronologic age).

You may qualify if:

  • A patient who was administered Somatropin (Genotropin).

You may not qualify if:

  • N/A.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Interventions

Human Growth Hormone

Intervention Hierarchy (Ancestors)

Growth HormonePituitary Hormones, AnteriorPituitary HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsPeptidesAmino Acids, Peptides, and Proteins

Results Point of Contact

Title
Pfizer ClinicalTrials.gov Call Center
Organization
Pfizer Inc.

Study Officials

  • Pfizer CT.gov Call Center

    Pfizer

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 9, 2013

First Posted

July 12, 2013

Study Start

September 5, 2013

Primary Completion

February 28, 2017

Study Completion

June 7, 2017

Last Updated

September 25, 2023

Results First Posted

February 11, 2020

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical\_trials/trial\_data\_and\_results/data\_requests.